Page last updated: 2024-10-30

losartan and Carcinoma

losartan has been researched along with Carcinoma in 2 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.

Research Excerpts

ExcerptRelevanceReference
"Operated human gastric cancer tissues from a 49-year-old and a 66-year-old male patients were also investigated."1.31Decreased binding sites of angiotensin II in rat LY-80 and AH109A tumour and human gastric cancer using quantitative in vitro autoradiography. ( Hori, K; Kohzuki, M; Sato, T; Suzuki, M; Tanda, S; Yoshida, K, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diop-Frimpong, B1
Chauhan, VP1
Krane, S1
Boucher, Y1
Jain, RK1
Kohzuki, M1
Tanda, S1
Hori, K1
Suzuki, M1
Yoshida, K1
Sato, T1

Other Studies

2 other studies available for losartan and Carcinoma

ArticleYear
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Feb-15, Volume: 108, Issue:7

    Topics: Analysis of Variance; Animals; Breast Neoplasms; Carcinoma; Collagen; DNA Primers; Dose-Response Rel

2011
Decreased binding sites of angiotensin II in rat LY-80 and AH109A tumour and human gastric cancer using quantitative in vitro autoradiography.
    International angiology : a journal of the International Union of Angiology, 2000, Volume: 19, Issue:1

    Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blocke

2000